Literature DB >> 10632434

Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis.

J L Mahnke1, M Y Dawood, J C Huang.   

Abstract

OBJECTIVE(S): To determine [1] vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) levels in peritoneal fluid from women with endometriosis and compare them with those from oral contraceptive (OC) users and normal cycling women and [2] any correlation between VEGF and IL-6 concentrations.
DESIGN: Controlled clinical study.
SETTING: University medical center. PATIENT(S): Patients undergoing laparoscopy for infertility or other benign gynecologic conditions. INTERVENTION(S): Peritoneal fluid samples were collected. MAIN OUTCOME MEASURE(S): Levels of VEGF and IL-6 in peritoneal fluid were determined. RESULT(S): Compared with normal controls or women with less severe endometriosis (implant scores of 5 or less), women with more advanced endometriosis (implant scores of 6 or more) have elevated VEGF and IL-6 levels in peritoneal fluid. Compared with normal controls, markedly suppressed IL-6 but similar VEGF levels were found in peritoneal fluid from OC users. Neither VEGF nor IL-6 varied cyclically in normal women or those with endometriosis. There was no correlation between levels of VEGF and IL-6 in peritoneal fluid. There was no correlation between implant scores and VEGF or IL-6 levels.
CONCLUSION: The inflammation associated with endometriosis, through increased levels of peritoneal fluid VEGF, may promote angiogenesis for the progressive growth of endometriosis. Effective treatment of endometriosis by combination estrogen-progestin pills may involve the suppression of such inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632434     DOI: 10.1016/s0015-0282(99)00466-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  18 in total

1.  Antioxidant supplementation reduces endometriosis-related pelvic pain in humans.

Authors:  Nalini Santanam; Nino Kavtaradze; Ana Murphy; Celia Dominguez; Sampath Parthasarathy
Journal:  Transl Res       Date:  2012-05-31       Impact factor: 7.012

2.  Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

Authors:  Mamadou Keita; Paul Bessette; Manuella Pelmus; Youssef Ainmelk; Aziz Aris
Journal:  J Ovarian Res       Date:  2010-01-28       Impact factor: 4.234

3.  mRNA-binding protein TIA-1 reduces cytokine expression in human endometrial stromal cells and is down-regulated in ectopic endometrium.

Authors:  Hakan Mete Karalok; Ebru Aydin; Ozlen Saglam; Aysenur Torun; Ozlem Guzeloglu-Kayisli; Maria D Lalioti; Helena Kristiansson; Cindy M P Duke; Gina Choe; Clare Flannery; Caleb B Kallen; Emre Seli
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

4.  ATR-IR Spectroscopy Application to Diagnostic Screening of Advanced Endometriosis.

Authors:  Izabela Kokot; Sylwester Mazurek; Agnieszka Piwowar; Roman Szostak; Marcin Jędryka; Ewa Maria Kratz
Journal:  Oxid Med Cell Longev       Date:  2022-06-06       Impact factor: 7.310

5.  Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study.

Authors:  Holly R Harris; Jorge E Chavarro; Susan Malspeis; Walter C Willett; Stacey A Missmer
Journal:  Am J Epidemiol       Date:  2013-02-03       Impact factor: 4.897

6.  Alternative activation of macrophages in rhesus macaques (Macaca mulatta) with endometriosis.

Authors:  Kumari A Smith; Christine B Pearson; Audra M Hachey; Dong-Ling Xia; Lynn M Wachtman
Journal:  Comp Med       Date:  2012-08       Impact factor: 0.982

7.  A candidate gene approach for virally induced cancer with application to HIV-related Kaposi's sarcoma.

Authors:  Brahim Aissani; Howard W Wiener; Kui Zhang; Richard A Kaslow; Kisani M Ogwaro; Sadeep Shrestha; Lisa P Jacobson
Journal:  Int J Cancer       Date:  2013-07-27       Impact factor: 7.396

Review 8.  Pathophysiology and Immune Dysfunction in Endometriosis.

Authors:  Soo Hyun Ahn; Stephany P Monsanto; Caragh Miller; Sukhbir S Singh; Richard Thomas; Chandrakant Tayade
Journal:  Biomed Res Int       Date:  2015-07-12       Impact factor: 3.411

9.  The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis.

Authors:  Graciela Krikun; Zhiwei Hu; Kevin Osteen; Kaylon L Bruner-Tran; Frederick Schatz; Hugh S Taylor; Paolo Toti; Felice Arcuri; William Konigsberg; Alan Garen; Carmen J Booth; Charles J Lockwood
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

10.  IL-6 and mouse oocyte spindle.

Authors:  Jashoman Banerjee; Rakesh Sharma; Ashok Agarwal; Dhiman Maitra; Michael P Diamond; Husam M Abu-Soud
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.